Search details
1.
Randomized controlled trial of high-dose versus standard-dose vitamin D3 for prevention of aromatase inhibitor-induced arthralgia.
Breast Cancer Res Treat
; 177(2): 427-435, 2019 Sep.
Article
in English
| MEDLINE | ID: mdl-31218477
2.
Low PTEN levels and PIK3CA mutations predict resistance to neoadjuvant lapatinib and trastuzumab without chemotherapy in patients with HER2 over-expressing breast cancer.
Breast Cancer Res Treat
; 167(3): 731-740, 2018 02.
Article
in English
| MEDLINE | ID: mdl-29110152
3.
Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach.
iScience
; 26(1): 105799, 2023 Jan 20.
Article
in English
| MEDLINE | ID: mdl-36619972
4.
A Multiparameter Molecular Classifier to Predict Response to Neoadjuvant Lapatinib plus Trastuzumab without Chemotherapy in HER2+ Breast Cancer.
Clin Cancer Res
; 29(16): 3101-3109, 2023 08 15.
Article
in English
| MEDLINE | ID: mdl-37195235
5.
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features.
Proc Natl Acad Sci U S A
; 106(33): 13820-5, 2009 Aug 18.
Article
in English
| MEDLINE | ID: mdl-19666588
6.
TBCRC023: A Randomized Phase II Neoadjuvant Trial of Lapatinib Plus Trastuzumab Without Chemotherapy for 12 versus 24 Weeks in Patients with HER2-Positive Breast Cancer.
Clin Cancer Res
; 26(4): 821-827, 2020 02 15.
Article
in English
| MEDLINE | ID: mdl-31662331
7.
HER2-Enriched Subtype and ERBB2 Expression in HER2-Positive Breast Cancer Treated with Dual HER2 Blockade.
J Natl Cancer Inst
; 112(1): 46-54, 2020 01 01.
Article
in English
| MEDLINE | ID: mdl-31037288
8.
Evaluation of the Predictive Role of Tumor Immune Infiltrate in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Anti-HER2 Therapy without Chemotherapy.
Clin Cancer Res
; 26(3): 738-745, 2020 02 01.
Article
in English
| MEDLINE | ID: mdl-31653641
9.
Upregulation of ER Signaling as an Adaptive Mechanism of Cell Survival in HER2-Positive Breast Tumors Treated with Anti-HER2 Therapy.
Clin Cancer Res
; 21(17): 3995-4003, 2015 Sep 01.
Article
in English
| MEDLINE | ID: mdl-26015514
10.
Development of acneiform rash does not predict response to lapatinib treatment in patients with breast cancer.
Pharmacotherapy
; 33(10): 1126-9, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23744830
11.
Multicenter phase II study of neoadjuvant lapatinib and trastuzumab with hormonal therapy and without chemotherapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer: TBCRC 006.
J Clin Oncol
; 31(14): 1726-31, 2013 May 10.
Article
in English
| MEDLINE | ID: mdl-23569315
12.
A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models.
Cancer Res
; 73(15): 4885-97, 2013 Aug 01.
Article
in English
| MEDLINE | ID: mdl-23737486
13.
Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy.
J Natl Cancer Inst
; 100(9): 672-9, 2008 May 07.
Article
in English
| MEDLINE | ID: mdl-18445819
Results
1 -
13
de 13
1
Next >
>>